INS and diabetes mellitus: Consequently, PTB1B inhibitor has the potential to stimulate insulin-regulated glucose uptake, enhance insulin sensitivity, and mitigate insulin resistance, and it is regarded as a promising therapeutic agent for the treatment of diabetes [123].